Compromised respiratory function in lethal influenza infection is characterized by the depletion of type I alveolar epithelial cells beyond threshold levels.

During influenza virus infection, it is unclear how much alveolar cell loss can be tolerated before the host succumbs to the disease. We sought to define relevant correlates of disease severity in the mouse influenza model, hypothesizing that a susceptibility threshold exists for alveolar epithelial cell loss. We compared lung pathology, virus spread, alveolar epithelial cell depletion, arterial blood oxygenation, physiological responses measured by unrestrained plethysmography, and oxygen consumption and carbon dioxide production by gas analysis in mice at intervals after infection with virus strains and doses that cause mild (x31) or severe (PR/8) influenza. Both mild and severe infections showed similar degrees of lung damage and virus dissemination until day 6 after inoculation but diverged in survival outcomes from day 9. Day 6 PR/8-infected mice had normal respiratory and gas exchange functions with 10% type I cell loss. However, day 10 PR/8-infected mice had 40% type I cell loss with a concomitant drastic decreases in tidal and minute volumes, Vo(2), Vco(2), and arterial blood oxygenation, compared with a maximum 3% type I cell loss for x31 on day 10 when they recovered body weight and respiratory functions. Alterations in breaths per minute, expiratory time, and metabolic rate were observed in both infections. A threshold for maintenance of proper respiratory function appears to be crossed once 10% of alveolar type I cells are lost. These data indicate that lethality in influenza virus infection is a matter of degree rather than quality.

[1]  G. Kochs,et al.  Altered receptor specificity and fusion activity of the haemagglutinin contribute to high virulence of a mouse-adapted influenza A virus. , 2012, The Journal of general virology.

[2]  B. Han,et al.  Cardiovascular , Pulmonary and Renal Pathology Functions of Type II Pneumocyte-Derived Vascular Endothelial Growth Factor in Alveolar Structure , Acute Inflammation , and Vascular Permeability , 2010 .

[3]  M. Jordana,et al.  Critical role of natural killer cells in lung immunopathology during influenza infection in mice. , 2012, The Journal of infectious diseases.

[4]  J. Taubenberger,et al.  The pathology of influenza virus infections. , 2008, Annual review of pathology.

[5]  P. Paré,et al.  The use and misuse of Penh in animal models of lung disease. , 2004, American journal of respiratory cell and molecular biology.

[6]  R. Mason Biology of alveolar type II cells , 2006, Respirology.

[7]  Y. Guan,et al.  Influenza H5N1 virus infection of polarized human alveolar epithelial cells and lung microvascular endothelial cells , 2009, Respiratory research.

[8]  D. Calame,et al.  Transplantation of human embryonic stem cell-derived alveolar epithelial type II cells abrogates acute lung injury in mice. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  M. Kasper,et al.  The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair , 2004, European Respiratory Journal.

[10]  K. Jones,et al.  Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. , 2002, American journal of respiratory and critical care medicine.

[11]  M. Chan,et al.  Viral Replication and Innate Host Responses in Primary Human Alveolar Epithelial Cells and Alveolar Macrophages Infected with Influenza H5N1 and H1N1 Viruses , 2011, Journal of Virology.

[12]  Ruslan Medzhitov,et al.  Disease Tolerance as a Defense Strategy , 2012, Science.

[13]  B. Uhal,et al.  Type II pneumocyte proliferation in vitro: problems and future directions. , 1991 .

[14]  D. Kioussis,et al.  Contribution of  Virus-specific CD8+ Cytotoxic T Cells to Virus Clearance or Pathologic Manifestations of Influenza Virus Infection in a T Cell Receptor Transgenic Mouse Model , 1998, The Journal of experimental medicine.

[15]  Matthias Mack,et al.  Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand , 2008, The Journal of experimental medicine.

[16]  Y. Guan,et al.  Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells , 2005, Respiratory research.

[17]  K. To,et al.  The comparative pathology of severe acute respiratory syndrome and avian influenza A subtype H5N1—a review , 2006, Human Pathology.

[18]  A. Gruber,et al.  Influenza A Viruses Target Type II Pneumocytes in the Human Lung , 2012, The Journal of infectious diseases.

[19]  M. White,et al.  Natural protection from apoptosis by surfactant protein A in type II pneumocytes. , 2001, Experimental cell research.

[20]  W. Janssen,et al.  Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus , 2012, Respiratory Research.

[21]  C. Korteweg,et al.  Pathology, Molecular Biology, and Pathogenesis of Avian Influenza A (H5N1) Infection in Humans , 2008, The American Journal of Pathology.

[22]  N. Van Rooijen,et al.  Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis , 2011, The American Journal of Pathology.

[23]  K. Ungchusak,et al.  Apoptosis and Pathogenesis of Avian Influenza A (H5N1) Virus in Humans , 2007, Emerging Infectious Diseases.

[24]  D. Smee,et al.  Use of plethysmography in assessing the efficacy of antivirals in a mouse model of pandemic influenza A virus. , 2011, Antiviral research.

[25]  Jeannette Guarner,et al.  Comparison of the pathology caused by H1N1, H5N1, and H3N2 influenza viruses. , 2009, Archives of medical research.

[26]  D. Bruder,et al.  Cellular immunity and lung injury in respiratory virus infection. , 2006, Viral immunology.

[27]  Z. Hantos,et al.  Penh is not a validated technique for measuring airway function in mice. , 2005, American journal of respiratory and critical care medicine.

[28]  J. Pittet,et al.  A type I cell-specific protein is a biochemical marker of epithelial injury in a rat model of pneumonia. , 1995, The American journal of physiology.